Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $50M Series A (Mar 2026) led by RRE Ventures and Creandum with Franklin Templeton, Coinbase Ventures, Anchorage Digital. $1.7B+ minted, $500M+ TVL, 20K+ holders.
Midas is a tokenization platform that creates composable on-chain investment products — tokenized versions of institutional assets including US Treasuries, money market funds, and corporate credit — that can be used as collateral in DeFi protocols, integrated into wallets, and transferred on-chain with the efficiency advantages of blockchain settlement. The company raised $50 million in Series A financing in March 2026, led by RRE Ventures and Creandum, with Franklin Templeton, Coinbase Ventures, and Anchorage Digital as strategic co-investors. Midas has minted $1.7 billion+ in assets with $500 million+ in total value locked across 20,000+ holders.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.